Navigation Links
Accelrys to Present to Investors at C.E. Unterberg Emerging Growth,Opportunities Conference

SAN DIEGO--(BUSINESS WIRE)--Jul 2, 2007 - Accelrys, Inc. (NASDAQ:ACCL), the leading provider of scientific business intelligence software and services, announced today that its CFO, Rick Russo, will present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference in New York on July 11, 2007 at 10:30 a.m. ET. The conference will take place at the Mandarin Oriental Hotel July 10th-12th. In attendance will be securities analysts, fund managers, and institutional investors.

The company will host a live web cast of the conference presentation at 10:30 a.m. ET on Wednesday, July 11, 2007. This web cast can be accessed through the Investor Relations section of Accelrys' web site at www.accelrys.com or by visiting the following web address: http://www.wsw.com/webcast/ceut6/accl/.

To learn more about C.E. Unterberg, Towbin, please visit www.unterberg.com.

About Accelrys, Inc.

Accelrys develops and commercializes Scientific Business Intelligence(TM) software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Our solutions are used by biologists, chemists, materials scientists, and information technology professionals for product design as well as drug discovery and development. Our technology and services are designed to meet the needs of today's leading research and development organizations including leading commercial, government and academic organizations. Many of the largest pharmaceutical, biotechnology, chemical, and petroleum companies worldwide use our solutions. Accelrys is headquartered in San Diego, California. For more information about Accelrys, visit its website at http://www.accelrys.com/.

Contact

Accelrys, Inc.
Philomena Walsh, 858-799-5440
pwalsh@accelrys.com
or
MKR Group, Inc.
Todd Ke hrli, 323-468-2300
accl@mkr-group.com


'"/>




Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2018)... ... 29, 2018 , ... More than 205,000 individuals have signed the 4th Annual ... significantly increase funding for type 1 diabetes cure research after spending on such initiatives ... An estimated two million Americans are affected by type 1 diabetes, and about half ...
(Date:11/28/2018)... , ... November 28, 2018 , ... ... is pleased to announce a new partnership with CME Master, a division of ... Middle East, with expansion into South East Asia expected soon. This new collaboration ...
(Date:11/28/2018)... CITY (PRWEB) , ... November 28, 2018 , ... nJoy ... high levels of myopia and astigmatism in one easy procedure following FDA approval of ... the Toric ICL, is scheduled at nJoy Vision OKC on November 29th by Edward ...
Breaking Medicine Technology:
(Date:12/10/2018)... , ... December 10, 2018 , ... ... the "100 hospitals and health systems with great heart programs." , The hospitals ... in their cardiology and cardiovascular surgery programs. Many institutions pioneered groundbreaking procedures and ...
(Date:12/10/2018)... ... 10, 2018 , ... Florida Hospital, soon to be AdventHealth, ... recently received the 2018 Press Ganey Guardian of Excellence Award® for achieving and ... and inpatient services is measured through random, voluntary patient surveys and the scores ...
(Date:12/8/2018)... ... December 07, 2018 , ... Caring.com, the nation’s most visited website for senior ... alert systems, to its list of top medical alert systems for 2019. The medical ... Guardian was one of fourteen companies that qualified for the list based on its ...
(Date:12/6/2018)... ... December 06, 2018 , ... We all know stress ... alternative solutions. M.D.-formulated Relaxium Calm is a dietary supplement developed to promote relaxation ... an extract of the ashwagandha root. Ashwagandha is a powerful herb that has ...
(Date:12/5/2018)... , ... December 05, 2018 , ... ... SkinPen Precision device is setting a new standard as the premier FDA-cleared microneedling ... , Each year this award is presented at the renowned Aesthetics Awards to ...
Breaking Medicine News(10 mins):